Publications by authors named "Alyson Connor"

Claim this Profile
R
Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study.
Tine A Baekdal, Morten Donsmark, Marie-Louise Hartoft-Nielsen, Flemming L Søndergaard, Alyson Connor

Clin Pharmacol Drug Dev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers.
Ofir Moreno, Todd Butler, Vanessa Zann, Ashley Willson, Pui Leung, Alyson Connor

Clin Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double-Blind, Randomized, Placebo-Controlled Phase 1 Clinical Study.
Hazel Hunt, Kirsteen Donaldson, Mark Strem, Vanessa Zann, Pui Leung, Alyson Connor

Clin Pharmacol Drug Dev· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for Raltegravir.
Rajesh Krishna, Matthew L Rizk, Patrick J Larson, Valerie Schulz, Evan Friedman, Alyson Connor

Ther Innov Regul Sci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule.
Dolly A Parasrampuria, Taro Kanamaru, Alyson Connor, Ian Wilding, Koichiro Ogata

J Clin Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional deposition of mometasone furoate nasal spray suspension in humans.
Samir A Shah, Robert L Berger, John McDermott, Pranav Gupta, David Monteith, Alyson Connor

Allergy Asthma Proc· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.
Avinash G Thombre, Sheri L Shamblin, Bimal K Malhotra, Alyson L Connor, Ian R Wilding

J Control Release· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
Ivor A Emanuel, Michael S Blaiss, Eli O Meltzer, Philip Evans, Alyson Connor

Am J Rhinol Allergy· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study.
Daisuke Tsunashima, Akio Kawamura, Manabu Murakami, Taiji Sawamoto, Nas Undre, Alyson Connor

Clin Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies.
Hikaru Sugihara, Yuji Matsui, Hirofumi Takeuchi, Ian Wilding, Alyson Connor

Eur J Pharm Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-engineering the early development process for pulmonary drug-delivery products.
Alyson Connor, John McDermott

Ther Deliv· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of oral extended release formulations of 6-hydroxybuspirone.
Sarah J Nicholson, Peter Timmins, Randy C Dockens, Alyson Connor, Robert Croop

Biopharm Drug Dispos· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of LY545694 tosylate controlled release tablets through pharmacoscintigraphy.
Evelyn D Lobo, Mark D Argentine, David C Sperry, Alyson Connor, John McDermott

Pharm Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Location, location, location: gastrointestinal delivery site and its impact on absorption.
Alyson Connor

Ther Deliv· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible.
Micaela B Reddy, Alyson Connor, Barbara J Brennan, Peter N Morcos, Amy Zhou

Biopharm Drug Dispos· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers.
Kevin Smith, Michael Hopp, Gill Mundin, Simon Bond, Paul Bailey, Alyson Connor

Expert Opin Investig Drugs· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Armel Stockis, Maria Laura Sargentini-Maier, Christian Otoul, Alyson Connor, Ian Wilding

Clin Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment of human regional drug absorption of free acid and sodium salt forms of acipimox, in healthy volunteers, to direct modified release formulation strategy.
Rajeev Menon, Eugenio Cefali, Ian Wilding, Heather Wray, Alyson Connor

Biopharm Drug Dispos· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oral human drug absorption study to assess the impact of site of delivery on the bioavailability of bevirimat.
Alyson Connor, Phil Evans, Judy Doto, Corey Ellis, David E Martin

J Clin Pharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers.
Niharika Khanna, Richard Dalby, Alyson Connor, Ann Church, Jennifer Stern

Sex Transm Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers.
Masataka Katsuma, Shunsuke Watanabe, Shigeo Takemura, Kazuhiro Sako, Toyohiro Sawada, Alyson L Connor

J Pharm Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Ewart T Cole, Robert A Scott, Dominique Cade, Alyson L Connor, Ian R Wilding

Pharm Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.
Ian R Wilding, Alyson L Connor, Polly Carpenter, Christiane Rordorf, Janice Branson

Pharm Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric coated HPMC capsules designed to achieve intestinal targeting.
Ewart T Cole, Robert A Scott, Alyson L Connor, Ian R Wilding, Hans U Petereit

Int J Pharm· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis